Tafalgie Therapeutics
Marseille
About Tafalgie Therapeutics
Tafalgie Therapeutics is a CNRS and AMU spin-off company engaged in biopharmaceutical research. The company engaged in the development of a new scientific approach for next-generation treatments based on a breakthrough innovation: a mechanism of action derived from an endogenous secreted protein capable of modulating pain signals. It was founded in 2020 and is located in Marseille, France.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $14.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2025)
- Website: tafalgie.fr
- Phone: +33 0(0) 4 44 44 60 40
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/tafalgie-therapeutics-62537 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.